Humoral immune responses are dysregulated with aging but details remain incompletely understood. In particular, little is known about the effects of aging on T follicular helper (Tfh) CD4 cells, the subset that provides critical help to B cells for effective humoral immunity. We previously demonstrated that influenza vaccination increases a circulating Tfh (cTfh) subset that expresses ICOS and CD38, contains influenza-specific memory cells, and is correlated with antibody responses. To directly study the effects of aging on the cTfh response, we performed transcriptional profiling and cellular analysis before and after influenza vaccination in young and elderly adults. Several key differences in cTfh responses were revealed in the elderly. First, whole blood transcriptional profiling defined cross-validated genesets of youth versus aging and these genesets were, compared to other T cells, preferentially enriched in ICOS+CD38+ cTfh from young and elderly subjects, respectively, following vaccination. Second, vaccine-induced ICOS+CD38+ cTfh from the elderly were enriched for transcriptional signatures of inflammation including TNF-NFkB pathway activation. Indeed, we reveal a paradoxical positive effect of TNF signaling on Tfh providing help to B cells linked to survival circuits that may explain detrimental effects of TNF blockade on vaccine responses. Finally, vaccine-induced ICOS+CD38+ cTfh displayed strong enrichment for signatures of underlying age-associated biological changes.
Abstract:
Humoral immune responses are dysregulated with aging but details remain incompletely understood. In particular, little is known about the effects of aging on T follicular helper (Tfh) CD4 cells, the subset that provides critical help to B cells for effective humoral immunity. We previously demonstrated that influenza vaccination increases a circulating Tfh (cTfh) subset that expresses ICOS and CD38, contains influenza-specific memory cells, and is correlated with antibody responses. To directly study the effects of aging on the cTfh response, we performed transcriptional profiling and cellular analysis before and after influenza vaccination in young and elderly adults. Several key differences in cTfh responses were revealed in the elderly. First, whole blood transcriptional profiling defined cross-validated genesets of youth versus aging and these genesets were, compared to other T cells, preferentially enriched in ICOS+CD38+ cTfh from young and elderly subjects, respectively, following vaccination. Second, vaccine-induced ICOS+CD38+ cTfh from the elderly were enriched for transcriptional signatures of inflammation including TNF-NFkB pathway activation. Indeed, we reveal a paradoxical positive effect of TNF signaling on Tfh providing help to B cells linked to survival circuits that may explain detrimental effects of TNF blockade on vaccine responses. Finally, vaccine-induced ICOS+CD38+ cTfh displayed strong enrichment for signatures of underlying age-associated biological changes.
Thus, these data reveal key biological changes in cTfh during aging and also demonstrate the sensitivity of vaccine-induced cTfh to underlying changes in host physiology. This latter observation suggests that vaccine-induced cTfh could function as sensitive biosensors of underlying inflammatory and/or overall immune health.
Main Text:
Influenza vaccination induces strain-specific neutralizing antibodies in healthy adults, but this process is impaired with aging (1) (2) (3) (4) . Moreover, immunological aging, that may or may not be directly linked to chronological aging, is also associated with increased morbidity and mortality from infectious diseases (5, 6) . Studies of immunological aging and vaccines have identified mechanisms including alterations at the subcellular (7, 8) , cellular (9, 10) , and systems levels (11) (12) (13) (14) that lead to altered vaccine responses. Vaccination strategies that can effectively combat age-associated immune dysfunction are of great interest for rational vaccine design. Moreover, identifying strategies to define critical characteristics of overall immune fitness during aging would be of considerable utility for selecting appropriate immunological and other interventions for disease.
The production of class-switched, affinity-matured antibody by B cells is dependent on help from T follicular helper (Tfh) cells in germinal centers (GC) in lymphoid tissues (15) , but few studies have evaluated the effects of aging on the GC reaction and GC dependent cellular responses in humans. Suboptimal vaccine responses with aging have been associated with alterations in cellular pathways, such as increased TNF-NFkB signaling or activity (16) . For example, several studies observed a weak negative correlation between serum TNF and vaccine responses (9, (17) (18) (19) . However, therapeutic anti-TNF antibody treatment paradoxically did not result in improved humoral responses and instead led to reduced vaccine-induced antibody responses to pneumococcal and influenza vaccines (20) (21) (22) . Furthermore, mice deficient in TNF receptor 1 or TNF failed to make GC and were unable to mount sustained IgG responses to immunization (23) (24) (25) (26) . Thus, the role of TNF signaling in GC and Tfh responses remains poorly understood. Other aspects of Tfh biology that might be affected with aging include impaired cellular activation (27) , altered expression of key proteins such as Programmed Death 1 (PD-1, CD279) or Inducible Costimulator (ICOS, CD278) (10, 27) , or other pathway-level changes, such as in proliferation or metabolism (13, 28) . Understanding these age-associated alterations will be necessary for designing rational vaccines for the elderly.
In humans, directly studying the events leading to productive humoral immunity is challenging because lymphoid tissue is not readily available after vaccination. Several studies have examined a subset of CD4 T cells in human peripheral blood, termed circulating T follicular helper cells (cTfh), that possesses phenotypic, transcriptional, and functional similarities to lymphoid Tfh (29) (30) (31) (32) (33) (34) and have been used to interrogate vaccine responses. Some features of these cTfh likely reflect events in lymphoid tissue.
For example, vaccine-induced changes in cTfh correlate with changes in influenzaspecific antibody production (32) (33) (34) . The subset of cTfh expressing high ICOS and CD38 expands at 7 days after influenza vaccination, correlates with the plasmablast response, and includes recurring influenza-specific T cell receptor clonotypes each year after influenza vaccination (35) . Moreover, we have recently demonstrated that these ICOS + CD38 + cTfh can be found in human lymph and share characteristic features of GC Tfh (36) . Thus, cTfh may be useful as a cellular biomarker of immunological events including vaccination. Moreover, profiling cTfh may provide opportunities to identify underlying reasons for suboptimal vaccine responses in human populations including the elderly.
Here, we tested the effects of aging on cTfh after influenza vaccination.
Consistent with previous studies, the frequency of cTfh subsets responding to vaccination was largely unchanged in older subjects. However, transcriptional profiling revealed key age-associated differences in cTfh responses to influenza vaccination. In particular, transcriptional signatures downstream of TNF-NFkB signaling pathway were enriched in responding ICOS+CD38+ cTfh from elderly compared to young adults at 7 days after vaccination. This transcriptional program was associated with a pro-survival effect in these ICOS+CD38+ cTfh. In addition, transcriptional profiling revealed several pathway-level, age-related differences in activated cTfh responding to vaccination. In particular, on day 7 after vaccination ICOS+CD38+ cTfh from older subjects displayed transcriptional evidence of major alterations in IL2-STAT5 signaling, IL6-STAT3 signaling, and other pathways. Indeed, when examined for general signatures of aging versus youth, ICOS+CD38+ cTfh enriched far better for these signatures than other blood T cell types suggesting that vaccine-induced, or recently activated cTfh are a sensitive biomarker of underlying changes in immune fitness. Thus, these studies identify key changes in cTfh with age that may relate to altered humoral immunity following vaccination and also could provide insight for age-related increases in many autoimmune diseases manifest by autoantibodies. Moreover, activated cTfh may be a useful circulating immune cell type acting as a type of biosensor into underlying changes in immune health and fitness.
Results

ICOS+CD38+ cTfh in young and elderly have a transcriptional signature similar to lymphoid Tfh
Antibody responses to vaccination depend on Tfh help in the B cell follicle (32, 33) , but the effects of aging on Tfh responses remain poorly understood. We and others have demonstrated that blood cTfh can provide insights Tfh biology relevant to vaccine responses (32) (33) (34) (35) . Moreover, cTfh expressing ICOS and CD38 expand after influenza vaccination and contain the influenza-specific cells (32, 35) and activated Tfh similar to those in the blood can be found in human lymph and have characteristics similar to GC Tfh, suggesting a direct relationship between ICOS+CD38+ cTfh and events in lymphoid tissue (36) . In this study, we therefore focused on the ICOS+CD38+ cTfh subset to understand age-related changes in vaccine-induced immunity.
We first sought to investigate the ICOS+CD38+ cTfh subset in young and elderly adults (Supplemental Table 1 ). We defined cTfh as non-naïve CD4+CXCR5+PD-1+ (Supplemental Figure 1A , Supplemental Table 2 ) (32, 35) . The frequency of cTfh expressing ICOS and CD38 was similar in young and elderly subjects at baseline and, though the frequency of this cTfh subset increased after influenza vaccination, it was not different between young and elderly subjects ( We next hypothesized that transcriptional profiling may be more sensitive than flow cytometric analysis for revealing differences in cTfh responses. We performed RNAseq on ICOS+CD38+ cTfh, ICOS-CD38-cTfh, and naïve CD4 + cells, from young (n=6) and elderly (n=8) adults before and after influenza vaccination (Supplemental Figure 1F -H). In both age groups, ICOS+CD38+ cTfh had a distinct transcriptomic signature, with higher expression of genes such as MAF, BCL6, and TIGIT as compared to naïve CD4, and ICOS+CD38+ cTfh expressed more CD38, MKI67, and POU2AF1 than ICOS-CD38-cTfh ( Figure 1F, Supplemental Figure 1I ). Moreover, the ICOS+CD38+ cTfh displayed greater similarity to lymphoid GC Tfh than the ICOS-CD38-cTfh subset by gene set enrichment analyses (GSEA) (37) for human tonsillar GC Tfh (30) and mouse lymphoid GC-Tfh (38, 39) datasets (Supplemental Figure 1J- Table 3 ), irrespective of aging. However, there were differences associated with aging at the level of individual gene expression, such as lower expression of POU2AF1 in elderly at baseline (fold-change 0.76, P=0.058, t-test, 6 young and 8 elderly) ( Figure 1F ) and at day 7 after vaccination (fold-change 0.78, P=0.024, t-test, 6 young and 8 elderly) (Supplemental Figure 1I ) that suggested that broader age-related differences might be uncovered at the pathway level.
L, Supplemental
TNF-NFkB signaling is enriched with aging in ICOS+CD38+ cTfh
To identify age-related differences in the cTfh response to vaccination, we directly compared the transcriptional profiles of ICOS+CD38+ cTfh from young and elderly subjects at day 7 (Figure 2A) , when the ICOS+CD38+ cTfh population in blood is enriched for influenza-specific cells (35) . Differential transcriptional profiles were apparent for ICOS+CD38+ cTfh from young compared to elderly subjects at day 7 (Supplemental Figure 2A-B) . Differentially expressed genes including PLCG2, RNF130, RAB2A, and ACSL3 that were increased in cTfh from elderly subjects, whereas CD27, CD6, EIF1AD, EEF2, and MAP2K2 were increased in the young (Supplemental Figure 2B ). CD27, a member of the TNF receptor family, was indeed more strongly expressed at the protein level in the ICOS+CD38+ cTfh from young adults compared to elderly subjects (Supplemental Figure 2B) . GSEA also identified inflammatory signatures enriched in the ICOS+CD38+ cTfh from the elderly subjects at day 7 post vaccination, with the greatest enrichment for TNF-NFkB signaling (Supplemental Figure 2C ). Together, these data suggested that the NF-kB signaling pathway was differentially used or engaged by ICOS+CD38+ cTfh in elderly compared to young subjects at day 7 post-vaccination.
These observations provoked the hypothesis that inflammatory signals were driving transcriptional network differences in the vaccine-induced cTfh from elderly subjects. To investigate this possibility, we next applied weighted gene correlation network analysis (WGCNA) (40) to more deeply interrogate underlying transcriptional networks of vaccine induced cTfh from young versus elderly subjects. At day 7 after vaccination, six transcriptional modules were identified for the ICOS+CD38+ cTfh subset isolated from young adults, whereas eight transcriptional modules were identified from the elderly (Figure 2B -C, Supplemental Table 4 ). Although most modules in young overlapped with one or more modules in the elderly, two modules in the elderly (EM1 and EM4) did not have significant overlap with any module in the young adults ( Figure 2D, Supplemental Figures 2D-E) . To evaluate the underlying biology of these modules, we used GSEA on genes ranked by module membership for EM1 and EM4 (Figure 2E, Supplemental Figure 2F ) and found TNF-NFkB signaling to be the highest-scoring pathway associated with EM4. After filtering the EM4 gene list for transcription factors (41), we identified a dense network of six hub genes, IRAK3, MYD88, TNFAIP3, STAT5A, REL and TNFSF11, that had direct relevance to the NF-kB signaling pathway (Figure 2F , Supplemental Table 5 ). Additionally, Ingenuity Pathway analysis (IPA) for upstream regulators predicted LPS, IL1B, NFkB (complex), TNF, and MYD88 to be more activated in the elderly compared to young adults in ICOS+CD38+ cTfh at day 7 following vaccination ( Figure 2G, Supplemental Figure 2G ). In addition, several other inflammatory pathways were strongly enriched in EM4 including Inflammatory Response, TGF-β signaling, IL-2 STAT5 signaling, and IL-6 JAK STAT3 signaling as were signatures of hypoxia and complement (Figure 2E ). Module EM1 also enriched for inflammatory pathways as well as type I and type II interferon pathways (Supplemental Figure 2F ). Together, these results identified coordinated transcriptional changes reflecting inflammatory signaling in the elderly.
We then used gene set variation analysis (GSVA) (42) to investigate whether the plasma TNF concentrations had any relationship with the increase of the TNF-NFkB geneset signature in elderly patients 7 days after immunization (Supplemental Figure   2H ). However, no correlation was observed between the GSVA score for the TNF-NFkB gene set and the serum TNF concentration (Supplemental Figure 2I ), suggesting that serum TNF alone was not likely to have induced the observed TNF-NFkB transcriptional signature.
We next tested if there was evidence for constitutive upregulation and/or activation of the NFkB pathway ex vivo. Indeed, NFKB1 (p50) protein expression was elevated in ICOS+CD38+ cTfh from elderly compared to young adults (Figure 2H -I, Supplemental Figure 2J ) suggesting a greater activation of, or ability to activate, this pathway in response to inflammatory mediators in the ICOS+CD38+ cTfh from aged individuals. TNF signaling occurs via interaction of soluble or membrane-bound TNF with TNF receptors, CD120a and CD120b (TNFR1 and TNFR2, respectively), with soluble TNF signaling more strongly through TNFR1 than TNFR2 (43) . To test whether cTfh differentially expressed TNFR1 or TNFR2, transcriptional profiling data for CD4 T cell subsets was evaluated for TNFR1 (gene name TNFRSF1A) and TNFR2 (gene name TNFRSF1B). Indeed, ICOS+CD38+ cTfh had higher gene expression for TNFR1 and TNFR2 than other CD4 subsets at baseline (Supplemental Figure 2K ). Following vaccination, although expression of TNFRSF1B was similar between young and elderly subjects, TNFRSF1A expression in ICOS+CD38+ cTfh was increased in elderly 
TNF signaling promotes Tfh-B cell interactions
TNF-NFkB signaling with aging has been associated with age-related immune dysfunction (44) . Here, our transcriptional and network analyses highlighted a role for increased NF-kB signaling with aging within ICOS+CD38+ cTfh at day 7 postvaccination. We hypothesized that this TNF-NFkB signaling may adversely affect Tfh-B cell interactions. To test this idea we used a cTfh-B cell coculture system (32) .
Supernatants from these co-cultures revealed a correlation between subject age and TNF in the supernatant after 7 days of co-culture ( Figure 3A , Pearson r=0.35, P=0.048). Because these co-cultures used the same source of naïve allogeneic B cells from a single young donor, these data indicate greater production of TNF that occurred during in vitro cTfh-B cell interactions was due to cTfh from the elderly subjects.
Together, these data indicated an age-associated upregulation of the NFkB signaling pathway in the ICOS+CD38+ cTfh after vaccination that was associated with increased TNF production during Tfh-B cell interactions in the elderly.
To evaluate the functional role of TNF signaling in the Tfh-B cell interaction, these in vitro B cell help assays were extended as previously described (29, 30, 32) , using autologous naïve B cells and CD4 T cells from young adults. As expected cTfh were the major supplier of B cell help, as evidenced by higher IgM and IgG1 in supernatant after SEB stimulation compared to controls (Figure 3B-C) . Soluble, but not membrane-associated TNF, is thought to be needed for proper GC formation (45) . To further test the impact of TNF on the ability of cTfh to provide help, supplemental recombinant TNF protein or α-TNF antibody was added at the beginning of the coculture. Adding TNF did not augment B cell help and antibody production compared to SEB alone (Figure 3B-C) . In contrast, addition of α-TNF blocking antibodies reduced supernatant IgG1 concentrations 10-fold compared to SEB alone ( Figure 3C) . The differentiation of naïve B cells into CD19 + CD38 + CD20 lo plasmablasts was also reduced in the presence of α-TNF antibodies, but addition of TNF had no effect (Supplemental Given the co-culture data, we hypothesized that TNF-NFkB signaling may be associated with a beneficial effect on the humoral response in vivo. Influenza vaccination was associated with higher expression of TNFRSF1A in ICOS+CD38+ cTfh in the elderly compared to young adults following vaccination (Figure 2J-K) . Thus, we next compared expression of TNFRSF1A and TNFRSF1B to the neutralizing antibody responses. Examining young and elderly subjects together, TNFRSF1A expression by ICOS+CD38+ cTfh (but not other CD4 subsets) positively correlated with the foldchange in the strain-specific neutralizing antibody titers at day 28 compared to day 0 ( Figure 3D-E) . These data support the notion of a positive role for TNF-NFkB signaling in Tfh-B cell interactions. Moreover, these observations are consistent with observations that clinical TNF blockade resulted in reduced vaccine immunogenicity (20, 21) .
Since TNF blockade was associated with reduced survival of cTfh and B cells in cocultures in vitro, we next asked if there was an association between TNF signaling and cell death in vivo. Indeed, GSVA scores for TNF-NFkB signaling correlated strongly with apoptosis, similarly for both age groups (Figure 3F ). This positive correlation seemed paradoxical given the in vitro data above. However, cells did not appear to be undergoing active regulated cell death (47) Figure 3H ), a cIAP family member that can restrain caspase-3 activation, was high in ICOS+CD38+ cTfh. Thus, together with the reduced viability in vitro with TNF blockade these data suggest that TNF-NFkB signaling may be necessary to counterbalance pro-apoptotic effects and foster cell survival circuits.
Vaccination elicits discordant transcriptional pathway responses with aging in ICOS+CD38+ cTfh
To better understand the full spectrum of transcriptional changes in cTfh during aging, we analyzed the vaccine-induced transcriptional signatures in ICOS+CD38+ cTfh on day 7 post vaccination compared to day 0 for young versus elderly subjects. Overall, influenza vaccination was associated with relatively modest changes in transcriptional profiles in ICOS+CD38+ cTfh from young and elderly ( Figure 4A) suggesting that prevaccination ICOS+CD38+ cTfh share many transcriptional characteristics with these cells post vaccination.
We then used pathway enrichment combined with pre-ranked GSEA to compare transcriptional signatures from ICOS+CD38+ cTfh from young versus elderly. Clear enrichment patterns were observed for many key gene sets. However, overall the enrichment patterns were only concordant between young and elderly subjects for ~1/3 
Age-related differences preferentially revealed by CD4 T cell subset analysis
We next hypothesized that the age-related differences in cellular pathways may be distinct in different CD4 T cell subsets. We therefore compared enrichment for nine Table 3 ). These analyses revealed several key findings. First, consistent with our data in ICOS+CD38+ cTfh (Figure 1) , most pathways showed minimal differences with aging at baseline, a finding pronounced for naïve CD4 T cells. Two exceptions included a moderate enrichment of the Myc targets biological pathway (Figure 5D ) in ICOS-CD38-cTfh and ICOS+CD38+ cTfh from the elderly at baseline and an enrichment of oxidative phosphorylation ( Figure 5F ) in the ICOS-CD38-cTfh from the young subjects at day 0. Second, the overall similarity at baseline was contrasted by substantial differences following influenza vaccination. Of all genesets, 57% changed in enrichment direction (i.e. from young to elderly or vice versa) for ICOS+CD38+ cTfh between days 0 and 7. However, one of the most clear patterns from these analyses was the uncovering of an underlying bias for inflammatory signatures including TNF-NFkB, Inflammatory Response and IL-2-STAT5 gene sets to be preferentially enriched in CD4 T cells of the elderly subjects, often with greatest enrichment in the ICOS+CD38+ cTfh subset (Figure 5A-C, J) . Third, ICOS+CD38+ cTfh showed the greatest dynamic range out of the three T cell subsets, based on the difference with aging in the day 7 and day 0 normalized enrichment scores per subset (Figure 5J ). Whether these differences reflect differential systemic induction of inflammation upon vaccination, distinct abilities of T cells from elderly versus young subject to induce transcriptional responses related to these pathways, or both, remains to be determined.
The different signatures of ICOS+CD38+ cTfh from young and elderly subjects are most apparent at day 7 post vaccination Differences in the transcriptional profiles CD4 T cells with aging were most prominent in ICOS+CD38+ cTfh at the cellular pathway level following influenza vaccination ( Figure 5 ). We next wanted to determine whether a whole-blood baseline gene signature of aging would be reflected in the same manner and whether vaccination was necessary to identify features of aging.
To test this idea, baseline whole-blood microarray data from the full study cohort (27 young and 35 elderly, Immport SDY739) was used to assess differential gene expression with aging, using the same cohort from which the subjects for the RNAseq (Figures 1-5 ) were derived. From these data, we constructed signatures of youth (354 genes upregulated in the young) or aging (232 genes upregulated in the elderly) (Supplemental Table 6 -7, Supplemental Figure 6A ). These signatures were then used to test whole-blood microarray data from other years' cohorts from the same study (48, 49) . We found strong enrichment of the signatures of youth and aging in the young and elderly adults, respectively ( Figure 6A) . The signature of youth had gene ontology terms for RNA metabolism whereas the signature of aging had terms for fatty acid metabolism and cytoskeletal regulation (Supplemental Figure 6B ), in agreement with other signatures of aging (28) .
To further validate these signatures, we identified several published studies (13, (50) (51) (52) that generated whole-blood transcriptional profiles on adults under age 40 or over age 65 ( Supplemental Table 8 ). From these data, we performed differential expression analysis of young compared to elderly in multiple geographically distinct studies and again found robust enrichment for these signatures in the external datasets ( Figure 6B, Supplemental Figure 6C) . To test these signatures on continuous (rather than cohorted) data, GSVA scores for the signatures of youth and aging were compared against the Nanostring data for subjects in a large cohort of humans (n=986) across lifespan (Milieu Interieur cohort). In this cohort, the signature of youth negatively correlated with chronological age (Pearson r=-0.28, P=8.6x10 -20 , n=986) and the signature of aging positively correlated with chronological age (Pearson r=0.31, P=4.6x10 -23 ) (Supplemental Figure 6D) . These results demonstrate conserved gene expression patterns for youth and aging in whole-blood transcriptional profiling data in multiple published studies.
We next tested whether the signatures of youth and aging could be discerned in the CD4 T cell subsets examined above before and after influenza vaccination. For example, the signature of youth was positively enriched in the young cohort in all subsets at day 0. However, this signature of youth was most strongly enriched in the ICOS+CD38+ cTfh at day 7 after vaccination (Figure 6C, Supplemental Figure 6E) .
Similarly, the signature of aging was evident at day 0, such as in naïve CD4 T cells from the elderly. Again, however, the strongest enrichment of the aging signature was revealed in the ICOS+CD38+ cTfh after vaccination (Figure 6C, Supplemental Figure   6E ). Together, these data demonstrated that ICOS+CD38+ cTfh are susceptible to immunologic perturbation with influenza vaccination and sensitively reflect general immunological or organismal environment of youth and aging in the cellular transcriptional program.
Discussion
Induction of protective antibody responses is the goal of most vaccines. Many vaccines are less effective in the elderly, but the underlying causes including how aging impacts Tfh and B cell responses remain poorly understood. In this study, we examined the cTfh response to vaccination in young and elderly adults to interrogate the effects of aging on Tfh. Although ICOS+CD38+ cTfh responses were similar in magnitude in young and older adults, many major cellular pathways were altered and these changes were apparent in the transcriptional signatures and transcriptional networks of these cells. There were several key observations from these studies. Increased baseline inflammation in the elderly has often been associated with declines in overall health (53) and, in particular, the TNF-NFkB pathway has been implicated in many pathological changes with aging. However, these correlations are at odds with the apparent detrimental effects of TNF pathway blockade on vaccination (20) (21) (22) that suggest that blocking residual TNF signaling impairs, rather than enhances, vaccine-induced antibody responses. Moreover, data from mice indicates a key role for TNF in GC responses (23) (24) (25) (26) Despite increased expression of pro-apoptotic Bcl family members such as BID in ICOS+CD38+ cTfh, there was a concomitant increase in expression of pro-survival factors BCL2A1 and MCL1 that strongly correlated with TNF-NFkB GSVA scores in ICOS+CD38+ cTfh at day 7 suggesting a TNF-NFkB-dependent survival signal in activated cTfh. These genes have NF-kB binding sites in their respective promoter sequences (54, 55) linking TNF signaling to a potential pro-survival circuit in these cells.
Moreover, TNFR1 expression in ICOS+CD38+ cTfh at day 7 positively correlated with neutralizing antibody production. These data are in agreement with, and may provide an explanation for, clinical data from patients receiving therapeutic TNF blockade demonstrating fewer GC reactions (56) and attenuated antibody responses to influenza vaccination (22) . These results may have direct implications for older adults receiving therapeutic TNF blockade, who may thus be at even greater risk for vaccine nonresponsiveness. Although these data suggested that the defects in vaccination in the elderly cannot be ascribed to TNF-NFkB activity in Tfh leading to reduced Tfh activity, it is possible that excessive Tfh activity impairs effective selection of high-quality antibody producing B cell clones. These results may also have implications for increases in autoreactive antibodies with age and/or age associated autoimmune diseases.
Although many circulating immune cell types can be altered with aging, our focus here on cTfh and CD4 T cells revealed a novel feature of vaccine-induced cTfh. By focusing on the ICOS+CD38+ cTfh population on day 7 after influenza vaccination, we found that these cells preferentially reflected underlying inflammatory and age-related biological signatures compared to ICOS-CD38-cTfh or naïve CD4 T cells. There are several potential reasons for this feature of ICOS+CD38+ cTfh. For example, the increase in the ICOS+CD38+ cTfh subset at day 7 post vaccination likely reflects an induction and/or reactivation of influenza-specific CD4 T cells, as this subset is enriched in influenza antigen-specific cells and similar TCR clones are recalled into this population upon yearly vaccination (35) . Thus, it is possible that these influenza specific T cells are qualitatively different from the ICOS+CD38+ cTfh circulating at baseline. However, a second related feature of these vaccine-induced cTfh relevant to these signature enrichments may be the synchronous nature of the responses. The ICOS+CD38+ cTfh responses at baseline likely reflect either ongoing chronically activated cTfh or cTfh in different phases of acute activation. In contrast, the vaccineinduced cTfh are aligned in their activation and differentiation kinetics, perhaps resulting in more focused transcriptional circuitry. Recent activation might also facilitate sensitivity and/or changes in inflammatory cytokine signaling as has been suggested for NFkB signaling in GC B cells (57) . In addition to enrichment for TNF-NFkB signaling and a broader signature of aging, activated cTfh also displayed transcriptional evidence of age-dependent alterations in many other pathways including other inflammatory circuits like IL2-STAT5 signaling, TGFβ pathway signaling, IL6-JAK-STAT3 signaling and several non-immune pathways. These observations were notable given the importance of both IL-2 and TNF-NFkB in Tfh biology and in inflammation (58) (59) (60) (61) . To aid in our understanding of the impacts of aging on cTfh, we constructed transcriptional signature maps of youth and aging based on whole-blood transcriptional profiling from 27 young and 34 elderly adults. These signatures were then validated using multiple geographically distinct cohorts, representing a total of 566 young adult samples and 344 elderly adult samples. The GSVA scores for the signatures of youth and aging from these dichotomous studies correlated with chronological age as a continuous variable in the Milieu Interieur study of nearly 1000 adults, with chronological age predicting 7.8-9.6% of the variance in the GSVA scores of our signatures. These analyses identified differential expression of RNA metabolism and regulation of cellular migration in the young and elderly, respectively, similar to other studies that have established signatures of aging (28) . Overall, these data indicated that the highest enrichment scores for our signatures of youth and aging were in the day 7 ICOS+CD38+ cTfh subset, demonstrating the advantage of profiling this subset to interrogate aging in the context of vaccine perturbation. These observations suggest that cTfh, and especially the synchronized, vaccine-induced cTfh at day 7 after influenza vaccination, may be sensitive biosensors of underlying features of immune inflammation or immune health.
Studies of the effects of aging on the vaccine-induced immune response are
needed to understand poor immune responses in aging adults who may be at heightened risk from infection. Rational vaccine strategies will require knowledge of how alterations in background host physiology, such as aging, impacts coordination of germinal center dependent antibody development and humoral immunity. These studies not only identify novel roles for inflammatory pathways in alterations of cTfh during aging, but also point to vaccine induced cTfh as a cell type that might provide a unique window into changes in overall immune health and fitness. Gene set enrichment analyses (37) were performed with at least 1000 permutations of pre-ranked GSEA (http://software.broadinstitute.org/gsea/downloads.jsp). Gene ontology was performed in Cytoscape using ClueGo (64, 65) or with Metascape (https://metascape.com) (66) . Ingenuity Pathway Analysis (Qiagen) was performed by uploading tables of the differential expression results from DESeq2 analyses for log 2 fold-change, p-values, and p-adjusted values, followed by Expression Analysis core analysis for all genes with p-value < 0.10.
Materials and Methods
Human subjects
Network analysis
Weighted gene correlation network analysis (WGCNA, version 1.63) (40) was performed on variance-stabilizing transformation data, as calculated by DESeq2 (63) after filtering out genes with less than 5 counts in fewer than 12% of all libraries. Adjacency matrix was calculated using β=20. Minimum module size was 100.
Gene ontology was analyzed using Metascape (66) for all genes with a module membership of at least 0.8. Pre-ranked GSEA was performed using all genes ranked by membership for each module. Transcription factors were identified from a curated list (41) and displayed with functional association data overlaid from GeneMANIA (67) .
Aging signature Transcriptional profiling data for whole blood microarray studies was obtained from the Gene Expression Omnibus (GEO accession numbers 123687, 123696, and 123698), from Immport (SDY622, SDY648, SDY739, and SDY819), and from the European Genome-phenome Archive (EGAS00001002460). For each dataset, subjects were stratified into cohorts for young adults (<40 years old) or elderly adults (>65 years old). Differential expression was calculated using GEO2R or by limma-voom (68) . An aging signature of 354 genes was constructed from genes downregulated in the elderly cohort from SDY739 with p.adj <0.20 using limma-voom. For analyses of the aging signature in CD4 subsets, pre-ranked GSEA analyses were performed with at least 25000 permutations and in subsets where FDR result was 0, the FDR was instead reported as 1/permutations or 4x10 -5 as per the GSEA Wiki FAQ entry 3.6. 
Influenza-specific antibodies
